SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-008429
Filing Date
2017-11-08
Accepted
2017-11-07 17:39:35
Documents
57
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q edit-20170930x10q.htm 10-Q 2097367
2 EX-10.1 edit-20170930ex101475b37.htm EX-10.1 44001
3 EX-10.2 edit-20170930ex102b3db43.htm EX-10.2 75802
4 EX-31.1 edit-20170930ex31116c052.htm EX-31.1 19714
5 EX-31.2 edit-20170930ex3128337cf.htm EX-31.2 19274
6 EX-32.1 edit-20170930ex321463161.htm EX-32.1 13568
  Complete submission text file 0001558370-17-008429.txt   6688429

Data Files

Seq Description Document Type Size
7 EX-101.INS edit-20170930.xml EX-101.INS 1238398
8 EX-101.SCH edit-20170930.xsd EX-101.SCH 49355
9 EX-101.CAL edit-20170930_cal.xml EX-101.CAL 41877
10 EX-101.DEF edit-20170930_def.xml EX-101.DEF 168990
11 EX-101.LAB edit-20170930_lab.xml EX-101.LAB 437563
12 EX-101.PRE edit-20170930_pre.xml EX-101.PRE 300125
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37687 | Film No.: 171184549
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences